Review
doi: 10.1038/sj.onc.1206548.
Virally targeted therapies for EBV-associated malignancies
Affiliations
- PMID: 12910249
- DOI: 10.1038/sj.onc.1206548
Item in Clipboard
Review
Virally targeted therapies for EBV-associated malignancies
Oncogene.
.
Abstract
In Epstein-Barr virus (EBV)-positive lymphomas, the presence of the EBV genome in virtually all tumor cells, but very few normal cells, suggests that novel, EBV-targeted therapies could be used to treat these malignancies. In this paper, we review a variety of different approaches currently under development that specifically target EBV-infected cells for destruction. EBV-based strategies for treating cancer include prevention of viral oncogene expression, inducing loss of the EBV episome, the purposeful induction of the lytic form of EBV infection, and enhancing the host immune response to virally encoded antigens.
Similar articles
-
Latent and lytic Epstein-Barr virus replication strategies.Rev Med Virol. 2005 Jan-Feb;15(1):3-15. doi: 10.1002/rmv.441. Rev Med Virol. 2005. PMID: 15386591 Review.
-
Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.Autoimmunity. 2008 May;41(4):298-328. doi: 10.1080/08916930802024772. Autoimmunity. 2008. PMID: 18432410 Review.
-
Detection of Epstein-Barr virus infection and gene expression in human tumors by microarray analysis.J Virol Methods. 2006 May;133(2):158-66. doi: 10.1016/j.jviromet.2005.10.032. Epub 2005 Dec 27. J Virol Methods. 2006. PMID: 16384612
-
Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia.Semin Cancer Biol. 2009 Jun;19(3):158-64. doi: 10.1016/j.semcancer.2009.02.012. Epub 2009 Feb 24. Semin Cancer Biol. 2009. PMID: 19429479 Review.
-
Lytic cycle switches of oncogenic human gammaherpesviruses.Adv Cancer Res. 2007;97:81-109. doi: 10.1016/S0065-230X(06)97004-3. Adv Cancer Res. 2007. PMID: 17419942 Review.
Cited by
-
Histone deacetylase inhibitors in Hodgkin lymphoma.Invest New Drugs. 2010 Dec;28 Suppl 1(Suppl 1):S21-7. doi: 10.1007/s10637-010-9588-y. Epub 2010 Dec 3. Invest New Drugs. 2010. PMID: 21127943 Free PMC article. Review.
-
Drugs That Mimic Hypoxia Selectively Target EBV-Positive Gastric Cancer Cells.Cancers (Basel). 2023 Mar 19;15(6):1846. doi: 10.3390/cancers15061846. Cancers (Basel). 2023. PMID: 36980731 Free PMC article.
-
Small molecule perturbation of the CAND1-Cullin1-ubiquitin cycle stabilizes p53 and triggers Epstein-Barr virus reactivation.PLoS Pathog. 2017 Jul 17;13(7):e1006517. doi: 10.1371/journal.ppat.1006517. eCollection 2017 Jul. PLoS Pathog. 2017. PMID: 28715492 Free PMC article.
-
Immunodominance of lytic cycle antigens in Epstein-Barr virus-specific CD4+ T cell preparations for therapy.PLoS One. 2007 Jul 4;2(7):e583. doi: 10.1371/journal.pone.0000583. PLoS One. 2007. PMID: 17611619 Free PMC article. Review.
-
EBV Exploits RNA m6A Modification to Promote Cell Survival and Progeny Virus Production During Lytic Cycle.Front Microbiol. 2022 Jun 15;13:870816. doi: 10.3389/fmicb.2022.870816. eCollection 2022. Front Microbiol. 2022. PMID: 35783391 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
